Press release from Companies: Hamlet Pharma achieves full funding from the European Commission

Press release from Companies: Hamlet Pharma achieves full funding from the European Commission

Press release from Companies: Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

Press release from Companies: Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

Press release from Companies: Kallelse till extra bolagsstämma i Hamlet Pharma AB (publ)

Market Notices: Market notice 83/23– Hamlet Pharma AB’s shares and subscription options HAMLET B and HAMLET TO 4 B is moved to the Observation List

Press release from Companies: Hamlet Pharma AB flyttas till observationslistan

Press release from Companies: Hamlet Pharma & SelectImmune Pharma invites to a digital investor meeting on April 3rd and April 4th at 12.00 CET

Press release from Companies: Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections

Press release from Companies: Hamlet Pharma och SelectImmune Pharma går samman för att skapa ett nydanande läkemedelsbolag med en bred och stark portfölj av projekt för behandling av cancer och infektioner

Press release from Companies: Hamlet Pharma’s achievements regarded as ‘‘exceptional’’ by the European Commission after final review of the Horizon 2020 project

Reports: Hamlet Pharma AB: Hamlet Pharma Q2 Interim Report October 2022 – December 2022